SiNtx Technologies Logo
US8293923079
A2PPL3
SINT

SiNtx Technologies

Loading quotes...

Forecast

Buy
  2
Hold
  1
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, SiNtx Technologies had revenue of €1.93M and net profit of -€1.41M
(EUR) September 2026
YoY
Revenue 1.93M 990.84%
Gross profit 1.2M 1,417.31%
Net profit -1.41M 83.89%
EBITDA -1.41M 50.98%

Fundamentals

Metric Value
Market capitalization
€9.22M
Number of shares
7.56M
52-week high/low
€4.05 - €1.21
Dividends No
Beta
0.59
P/E ratio
-0.60
PEG ratio
-0.01
P/B ratio
2.64
P/S ratio
3.02

Company profile

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Name
SiNtx Technologies
CEO
Eric K. Olson
Headquarters Salt Lake City, ut
USA
Website
Sector
Materials
Industry
Chemicals
IPO
02/13/2014
Employees 32

Ticker symbols

Exchange Symbol
NASDAQ
SINT
Frankfurt
111N.F
London
0A8S.L
München
111N.MU
🍪

Parqet  uses cookies. Learn more